SNY - Israel hospital says new COVD-19 therapy cured a majority of patients within days

A Phase 1 trial has demonstrated that a new coronavirus treatment helped patients with moderate-to-serious COVID-19 to recover within days, Tel Aviv’s Ichilov Medical Center said on Friday, according to The Times of Israel.Out of 30 patients with moderate or severe COVID-19, who received EXO-CD24, 29 have recovered within three to five days. The recovery took “a few days” longer for the other patient, said professor Nadir Arber, the lead researcher.“The new compound is inhaled once a day for a few minutes, for five days,” Arber said, adding that the trial led to a success rate of 96%. It fights the cytokine storm, an overreaction of the immune system against the virus, which can, eventually, lead to death. EXO-CD24 uses exosomes - important for intercellular communication and function - to deliver a protein named CD24 to the lungs. According to Shiran Shapira, a researcher in Arber’s research team, CD24 located on the surface of cells

For further details see:

Israel hospital says new COVD-19 therapy cured a majority of patients within days